March 12, 2025
The Roland Berger Business Insights podcast has launched its next series, which is all about Health topics. In the first episode, our experts
Thilo Kaltenbach and Stephan Fath explore the increasing pressure on pharmaceutical supply chains caused by global demand shifts, regulatory changes, and geopolitical uncertainties. Many essential medicines, including generics and biologics, are experiencing shortages due to highly concentrated manufacturing in a few regions. When disruptions occur, such as factory shutdowns or trade restrictions, entire markets can be affected. Governments and industry leaders are working to reduce these dependencies by incentivizing local production and strengthening regional supply networks, but implementation remains a challenge.
Beyond regulatory and logistical adjustments, technological advancements are shaping the future of pharmaceutical supply chains. AI-driven manufacturing and modular production systems offer new ways to enhance flexibility and efficiency. Companies are also evaluating how to balance cost-effectiveness with resilience, as shifting production to new locations requires significant investments in infrastructure and workforce development.
With healthcare systems increasingly reliant on stable drug supplies, the pharmaceutical industry is at a turning point. This episode explores how companies and policymakers can collaborate to create a more secure and adaptable supply chain. What strategies will prove most effective? And how will innovation drive the next phase of pharmaceutical production?
Listen to this episode on Apple Podcast, Spotify & Podigee and stay tuned for more episodes in this new series on Health topics.